Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Unresectable Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05346146
What this trial is testing

A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.

Who this might be right for
Unresectable Locally Advanced Pancreatic Cancer
RenJi Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01019382
What this trial is testing

The Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University Hospitals, Leicester 50
Testing effectiveness (Phase 2)WithdrawnNCT05216120
What this trial is testing

Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas

Who this might be right for
Pancreas Cancer
HonorHealth Research Institute
Very early researchUnknownNCT06478459
What this trial is testing

Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Zhejiang University 20
Testing effectiveness (Phase 2)Ended earlyNCT00553813
What this trial is testing

A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cortice Biosciences, Inc. 23
Large-scale testing (Phase 3)WithdrawnNCT03536182
What this trial is testing

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT00051467
What this trial is testing

TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GenVec
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Early research (Phase 1)WithdrawnNCT03925428
What this trial is testing

Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmAnn Arbor Stage III B-Cell Non-Hodgkin Lymphoma+14 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01118897
What this trial is testing

Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers

Who this might be right for
Pancreatic Neoplasms MalignantMalignant Neoplasm of Gall Bladder Non-resectable
Tata Memorial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02351219
What this trial is testing

FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma Stage III
Azienda Ospedaliero, Universitaria Pisana 50
Not applicableLooking for participantsNCT06984562
What this trial is testing

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA)
Fox Chase Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT03599362
What this trial is testing

Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health 7
Early research (Phase 1)Ended earlyNCT01302405
What this trial is testing

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Prism Pharma Co., Ltd. 23
Testing effectiveness (Phase 2)Looking for participantsNCT06831136
What this trial is testing

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The University of Texas Health Science Center, Houston 24
Not applicableUnknownNCT03964064
What this trial is testing

I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableBrachytherapyRadiotherapy
Peking University Third Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02358356
What this trial is testing

Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study

Who this might be right for
Midgut Neuroendocrine TumoursPancreatic Neuroendocrine Tumours
Australasian Gastro-Intestinal Trials Group 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07108504
What this trial is testing

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy Effect
Shanghai Zhongshan Hospital 30
Early research (Phase 1)Looking for participantsNCT07094204
What this trial is testing

Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Who this might be right for
Solid TumorNon-Small-Cell Lung CancerPancreatic Ductal Adenocarcinoma+1 more
Astellas Pharma Inc 364
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Next Page